GlassScriptPhysician profile
Marilyn P Smith
NPI 1598777542
$1,764.29
in general payments reported to CMS, 2019-2025
19 companies · $258 in 2025
The $258 reported for 2025 was more than what 81% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $277 · 2020: $218 · 2021: $301 · 2022: $158 · 2023: $280 · 2024: $273 · 2025: $258.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $811.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $810.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $422.23 | 2019-2025 | Doc Band |
| Tris Pharma INC | $402.57 | 2019-2025 | Dyanavel Xr, Onyda Xr, Quillichew Er |
| Kaleo, INC. | $198.97 | 2019-2024 | Auvi-Q |
| Glaxosmithkline, LLC. | $133.73 | 2019-2025 | Bexsero, Rotarix, Pediarix |
| Merck Sharp & Dohme LLC | $125.10 | 2020-2024 | Vaxneuvance, Vaxelis, Gardasil 9 |
| Takeda Pharmaceuticals U.S.A., INC. | $115.75 | 2020-2022 | |
| Verrica Pharmaceuticals INC. | $63.95 | 2023-2024 | Ycanth |
| Pfizer INC. | $51.71 | 2024-2025 | |
| Adlon Therapeutics L.P. | $45.26 | 2020-2021 | |
| Supernus Pharmaceuticals, INC. | $38.03 | 2025 | Qelbree |
| Ars Pharmaceuticals Operations, INC. | $24.22 | 2025 | Neffy |
| Mission Pharmacal Company | $21.31 | 2019 | |
| Corium, LLC | $19.50 | 2023 | Azstarys |
| Alk-Abello, INC | $19.46 | 2025 | Neffy |
| Sobi, INC | $19.10 | 2023 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amneal Pharmaceuticals LLC | $17.52 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $17.34 | 2025 | Zoryve |
| Shire North American Group INC | $15.65 | 2019 | |
| Sanofi Pasteur INC. | $12.89 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marilyn Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.